# Pharmacokinetic Study of Two Oral Bemiparin Formulations

> **NCT00863577** · PHASE1 · COMPLETED · sponsor: **Rovi Pharmaceuticals Laboratories** · enrollment: 102 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Oral bemiparin

## Key facts

- **NCT ID:** NCT00863577
- **Lead sponsor:** Rovi Pharmaceuticals Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2010-12
- **Final completion:** 2011-01
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2011-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00863577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00863577, "Pharmacokinetic Study of Two Oral Bemiparin Formulations". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00863577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*